India Pesticides Ltd Q1 FY2027 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/1p4xc2ed9kdkrc8dsr492zpj.pdf

Key Takeaways


Quarterly Performance

D. K. Jain: "See, this quarter we could get 15.5% and we feel that this is sustainable though we would like to increase. We agree the quarter is slightly subdued, but otherwise we had expected EBITDA of about 18%. As the overall geopolitical situation improves, we feel our margins will also improve."

Pretilachlor & Monsoon Impact

D. K. Jain: "Pretilachlor will remain very good product for paddy and we hope that we are the major player in this field and we will continue to do so."

New Products & EU Approval

D. K. Jain: "As we understand, there is no major producer of this product in India. We will be the major producer now in India for this product and this will be produced at our Sandila facility."

Capacity Expansion: Hamirpur & Sandila

S. P. Gupta: "Our object has been not to take any term loan in India Pesticide for its expansion and we have already a very healthy cash balance. So we will be funding our capex through internal accruals only."

Margins, Working Capital & Competitive Position

D. K. Jain: "We are trying to improve our operational efficiency and trying to compete with Chinese imports and that is where our R&D team is working regularly to optimize further the process conditions and we are also optimizing in engineering to reduce the overall project cost."

Guidance & Commitments

CommitmentSpecificsTimeline
FY27 top-line growthLower single-digit growth, with Q3 and Q4 expected to be betterFY27
Hamirpur FY27 revenue₹50–60 croresFY27
Hamirpur long-term revenue~₹1,000 crores turnover, installing 2 blocks every yearComing 3–4 years
Sandila long-term revenueAt least ₹1,000 crores, with 2 more blocks addedComing 4 years
EU TEQ incremental revenue₹30–40 crores, sales commencing from NovemberNovember onwards
New fungicide market captureAt least 2,000 tons of ~4,000–5,000 tons India import marketNo date
Inventory daysCome down to ~170Q3 FY27
Receivable daysRemain ~120Ongoing
EBITDA margin~18% if geopolitical situation improves; at least 15–16% sustainable2–3 years for ~18%
Capex fundingNo term loan; funded through internal accruals onlyOngoing

Key Metrics

MetricQ1 FY27
Revenue₹256 crores, down 9.2% YoY from ₹282 crores
EBITDA₹39 crores, down from ₹52 crores in Q1 FY26
EBITDA margin15.4%, down from 18.4% in Q1 FY26
PAT₹23 crores, down from ₹35 crores in Q1 FY26
PAT margin8.9%
Export revenue₹89 crores, up from ₹87 crores in Q1 FY26; approximately 35% of total revenue
Domestic revenue₹167 crores, down from ₹195 crores in Q1 FY26
Chemicals revenue₹181 crores
Formulations revenue₹72 crores
Volume decline~13%, offset by price rise of ~4%
FY27 revenue growth guidanceLower single-digit growth expected
Capacity utilization~70%
Receivable days~120 days, expected to remain stable
Inventory days~200 days, up from 170 days; expected to normalize to ~170 days in Q3
Cash balance₹59 crores as at 30th June
Hamirpur FY27 revenue expectation₹50–60 crores
Hamirpur long-term revenue potential~₹1,000 crores from 8–10 blocks, in 3–4 years
Sandila long-term revenue potentialAt least ₹1,000 crores in coming 4 years
Combined annual capex (Sandila + Hamirpur)~₹100 crores every year
New fungicide product import substitution4,000–5,000 tons imported annually; IPL targeting at least 2,000 tons capacity
New fungicide product price₹500–600 per kg
EU TEQ approval incremental revenue₹30–40 crores additional, on top of existing ~₹100 crores annual revenue
One-time export receivable write-off₹2.5 crores
Increased job work chargesHigher by ~₹6 crores